■ Unstable or uncontrolled psychiatric illness that, in the investigator's judgment, would interfere with safe study participation
Reproductive / Fertility ■ Actively pursuing fertility or planning conception during study participation
Prior / Concomitant Therapy
Current use of androgen replacement therapy, exogenous estrogen, or other endocrine-active agents that would confound study interpretation
Prior or current use of aromatase inhibitor or selective estrogen receptor modulator / degrader within 6 months of enrollment
General
■ Any other clinically significant medical condition, laboratory abnormality, or circumstance that, in the investigator's judgment, would place the participant at unacceptable risk or compromise study integrity
Clareo Health | Reversing InGuinal Hernia Trial: The Evaluation of Sex Hormones to Reverse Inguinal Hernias in Males
